Pieris Pharmaceuticals Profit Margin 2014-2021 | PIRS
Current and historical gross margin, operating margin and net profit margin for Pieris Pharmaceuticals (PIRS) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Pieris Pharmaceuticals net profit margin as of June 30, 2021 is -205.63%.
|Pieris Pharmaceuticals Annual Profit Margins
|Pieris Pharmaceuticals Quarterly Profit Margins
||Medical - Biomedical and Genetics
Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.